Cargando…
Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis
INTRODUCTION: The use of renin-angiotensin system (RAS) inhibitors, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), was alleged to cause a more severe course of novel coronavirus disease 2019 (COVID-19). METHODS: We systematically reviewed the pub...
Autores principales: | Hasan, Syed Shahzad, Kow, Chia Siang, Hadi, Muhammad Abdul, Zaidi, Syed Tabish Razi, Merchant, Hamid A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486167/ https://www.ncbi.nlm.nih.gov/pubmed/32918209 http://dx.doi.org/10.1007/s40256-020-00439-5 |
Ejemplares similares
-
Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020) -
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis
por: Hasan, Syed Shahzad, et al.
Publicado: (2020) -
Use of corticosteroids in asthma and COPD patients with or without COVID-19
por: Hasan, Syed Shahzad, et al.
Publicado: (2020) -
Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
por: Kow, Chia Siang, et al.
Publicado: (2021) -
Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures?
por: Hasan, Syed Shahzad, et al.
Publicado: (2021)